Search

everythinglearnresearchcommunity

for

Search:↓

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

Drug repurposing is a faster, cheaper way to develop new treatments using existing drugs.

Solanum nigrum shows promise for treating COVID-19 and its complications, but more research is needed.

COVID-19 can cause or worsen skin issues.

Platycladi Cacumen may help treat hair loss by targeting specific proteins and pathways.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

Raltegravir may cause hair loss in some patients.

An HIV patient's complete hair loss was reversed after switching from lopinavir/ritonavir to nelfinavir.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Indinavir, especially with vitamin A, may cause bone changes, but switching to nelfinavir can reduce these effects.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Indinavir and ritonavir therapy can cause reversible hair loss.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

[6]-Gingerdiol 3-monoacetate shows promise for treating T. whipplei infections.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Indinavir therapy can cause reversible skin, hair, and nail darkening.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

A 1-day or 3-day itraconazole treatment is effective for acute vulvovaginal candidosis, but recurrent cases may need longer treatment.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

A man's hair loss was linked to his HIV medication, which improved after changing drugs.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.

Some HIV treatments can harm mitochondria, potentially causing side effects like lactic acidosis and nerve damage.

A new delivery system makes Curcumin more effective and safer against viruses.